ESRD Network 13 Medwatch Database

To Search the ESRD Network 13 FDA Medwatch Database click here.

ESRD’s FDA Medwatch Listing

12/16/2015 FDA MedWatch – Rosiglitazone-containing Diabetes Medicines: Drug Safety Communication – FDA Eliminates the Risk Evaluation and Mitigation Strategy (REMS)
12/11/2015 FDA MedWatch – November 2015 Drug Safety Labeling Changes includes 19 products with revisions to Prescribing Information
12/04/2015 FDA MedWatch – SGLT2 Inhibitors: Drug Safety Communication – Labels to Include Warnings About Too Much Acid in the Blood and Serious Urinary Tract Infections
12/02/2015 FDA MedWatch – OmniPod Insulin Management System by Insulet: Field Safety Notification – Reported Cases of Needle Mechanism Deployment Failure or Delay
11/27/2015 FDA MedWatch – Compounded Multivitamins by Glades Drugs: Voluntary Recall – High Amounts of Vitamin D3 (Cholecalciferol)
11/25/2015 Recall: Baxter 15L Cycler Drainage Bags
11/23/2015 FDA MedWatch – Intravascular Medical Devices: FDA Safety Communication – Lubricious Coating Separation
11/13/2015 FDA MedWatch – October 2015 Drug Safety Labeling Changes includes 26 products with revisions to Prescribing Information
11/06/2015 FDA MedWatch – Plavix (clopidogrel): Drug Safety Communication – Long-term Treatment Does Not Change Risk of Death
10/29/2015 FDA MedWatch – Auvi-Q (epinephrine injection, USP): Recall – Potential Inaccurate Dosage Delivery